In addition to IL-17A production, IL-4 expression has been shown to inhibit the anti-tumor response of Vγ9+Vδ2+ T cells via the promotion of IL-10-producing Vδ1+ T cell growth [59]. This evidence concerns the gene IL17A and neoplasm.